407 related articles for article (PubMed ID: 15856232)
1. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
[TBL] [Abstract][Full Text] [Related]
2. Antileishmanial ring-substituted ether phospholipids.
Avlonitis N; Lekka E; Detsi A; Koufaki M; Calogeropoulou T; Scoulica E; Siapi E; Kyrikou I; Mavromoustakos T; Tsotinis A; Grdadolnik SG; Makriyannis A
J Med Chem; 2003 Feb; 46(5):755-67. PubMed ID: 12593656
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of potent antileishmanial cycloalkylidene-substituted ether phospholipid derivatives.
Calogeropoulou T; Angelou P; Detsi A; Fragiadaki I; Scoulica E
J Med Chem; 2008 Feb; 51(4):897-908. PubMed ID: 18220332
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of alkylphosphocholine derivatives: antineoplastic action on brain tumor cell lines in vitro.
Jendrossek V; Hammersen K; Erdlenbruch B; Kugler W; Krügener R; Eibl H; Lakomek M
Cancer Chemother Pharmacol; 2002 Jul; 50(1):71-9. PubMed ID: 12111115
[TBL] [Abstract][Full Text] [Related]
5. 3D-Quantitative structure-activity relationships of synthetic antileishmanial ring-substituted ether phospholipids.
Kapou A; Benetis NP; Avlonitis N; Calogeropoulou T; Koufaki M; Scoulica E; Nikolaropoulos SS; Mavromoustakos T
Bioorg Med Chem; 2007 Feb; 15(3):1252-65. PubMed ID: 17158053
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity studies with cytotoxic anthrapyrazoles.
Begleiter A; Lin D; Larson KK; Lang J; Wu X; Cabral T; Taylor H; Guziec LJ; Kerr PD; Hasinoff BB; Guziec FS
Oncol Rep; 2006 Jun; 15(6):1575-80. PubMed ID: 16685398
[TBL] [Abstract][Full Text] [Related]
7. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro.
Danhauser-Riedl S; Himmelmann A; Steinhauser G; Busch R; Vogler WR; Rastetter J; Berdel WE
J Lipid Mediat; 1990; 2(5):271-80. PubMed ID: 2133272
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and quantitative structure-activity relationship of cytotoxic gamma-carboline derivatives.
Chen J; Dong X; Liu T; Lou J; Jiang C; Huang W; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 May; 17(9):3324-31. PubMed ID: 19359185
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and structure-activity relationships of antiproliferative 1,3-disubstituted urea derivatives.
Li HQ; Zhu TT; Yan T; Luo Y; Zhu HL
Eur J Med Chem; 2009 Feb; 44(2):453-9. PubMed ID: 18514972
[TBL] [Abstract][Full Text] [Related]
11. 3-(4-Aroyl-1-methyl-1H-2-pyrrolyl)-N-hydroxy-2-propenamides as a new class of synthetic histone deacetylase inhibitors. 2. Effect of pyrrole-C2 and/or -C4 substitutions on biological activity.
Mai A; Massa S; Cerbara I; Valente S; Ragno R; Bottoni P; Scatena R; Loidl P; Brosch G
J Med Chem; 2004 Feb; 47(5):1098-109. PubMed ID: 14971890
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of some novel benzoxazole derivatives as anticancer, anti-HIV-1 and antimicrobial agents.
Rida SM; Ashour FA; El-Hawash SA; ElSemary MM; Badr MH; Shalaby MA
Eur J Med Chem; 2005 Sep; 40(9):949-59. PubMed ID: 16040162
[TBL] [Abstract][Full Text] [Related]
13. Antiinvasive activity of hexadecylphosphocholine in vitro.
Schallier DC; Bruyneel EA; Storme GA; Hilgard P; Mareel MM
Anticancer Res; 1991; 11(3):1285-92. PubMed ID: 1888162
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents.
Kock I; Heber D; Weide M; Wolschendorf U; Clement B
J Med Chem; 2005 Apr; 48(8):2772-7. PubMed ID: 15828815
[TBL] [Abstract][Full Text] [Related]
15. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
16. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
Al-Saadi MS; Rostom SA; Faidallah HM
Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
[TBL] [Abstract][Full Text] [Related]
17. 11H-Isoquino[4,3-c]cinnolin-12-ones; novel anticancer agents with potent topoisomerase I-targeting activity and cytotoxicity.
Ruchelman AL; Singh SK; Ray A; Wu X; Yang JM; Zhou N; Liu A; Liu LF; LaVoie EJ
Bioorg Med Chem; 2004 Feb; 12(4):795-806. PubMed ID: 14759740
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumoral activity of novel 3-(2-substituted-1,3,4-oxadiazol-5-yl) and 3-(5-substituted-1,2,4-triazol-3-yl) beta-carboline derivatives.
Formagio AS; Tonin LT; Foglio MA; Madjarof C; de Carvalho JE; da Costa WF; Cardoso FP; Sarragiotto MH
Bioorg Med Chem; 2008 Nov; 16(22):9660-7. PubMed ID: 18951806
[TBL] [Abstract][Full Text] [Related]
19. Induction of resistance in the human leukemia cell line HL60 towards hexadecylphosphocholine and other ether phospholipid analogues.
Berkovic D; Haase D; Hiddemann W; Fleer EA
J Exp Ther Oncol; 1996 Nov; 1(6):368-75. PubMed ID: 9414427
[TBL] [Abstract][Full Text] [Related]
20. A cationic amphiphilic peptide ABP-CM4 exhibits selective cytotoxicity against leukemia cells.
Chen YQ; Min C; Sang M; Han YY; Ma X; Xue XQ; Zhang SQ
Peptides; 2010 Aug; 31(8):1504-10. PubMed ID: 20493915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
